|
General Information
|
|
|
Product
|
TSLP Antibody
|
|
Description
|
Affinity Purified Thymic Stromal LymphoPoietin Antibody
|
|
Verified Applications
|
ELISA, IP, WB
|
|
Host
|
Rabbit
|
|
Species Cross Reactivity
|
Human
|
|
Immunogen
|
Synthetic peptide taken within amino acid region 50-100 on human Thymic Stromal LymphoPoietin.
|
|
Physical Properties
|
|
|
Quantity
|
100 µg
|
|
Volume
|
200 µl
|
|
Concentration
|
0.5-1.5 µg/µl in antibody stabilization buffer
|
|
Immunoglobulin
|
IgG
|
|
Form
|
Affinity Purified
|
|
Purification Method
|
Immobilized antigen affinity chromatography
|
|
Clonality
|
Polyclonal
|
|
Storage
|
-20C for long term storage
|
|
Application Protocol
|
|
ELISA
|
1:50,000
|
|
Immunoprecipitation
|
1:200
|
|
Western Blot
|
1:500-1:5,000
|
|
Protein
|
|
Uniprot #
|
Q969D9
|
|
Molecular Function
|
cytokine activity
interleukin-7 receptor binding
|
|
Subcellular Location
|
Extracellular region or secreted
|
|
Expression
|
Isoform 1 is expressed in a number of tissues including heart, liver and prostate. Isoform 2 is the predominant form in keratinocytes of oral mucosa, skin and in salivary glands. It is secreted into saliva.
|
|
Structure
|
Interacts with a receptor composed of CRLF2 and IL7R. Binding of TSLP to CRLF2/TSLPR is a mechanistic prerequisite for recruitment of IL7R to the high-affinity ternary complex.
|
|
Alternative Nomenclature
|
Thymic stromal lymphopoietin antibody
Thymic stromal lymphopoietin protein TSLP antibody
Tslp antibody
TSLP protein antibody
TSLP_HUMAN antibody
|
| |
|
TSLP Antibody BIOTIN
TSLP Positive Control
TSLP Blocking Peptide
TSLP Antibody FITC
